Skip to content
Clinical Trials – home

Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu

Verified siteinfo

Poland Ul. Borowska 213, 50-556 Wroclaw, Poland

  • 87 trials recruiting
  • Plasma cell myeloma · Chronic lymphocytic leukaemia · Acute myeloid leukaemia
  • Adults and children

About Specializations

Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu in Wroclaw, Poland specialises in clinical trials of conditions such as Plasma cell myeloma, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Cardiac failure, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Research

At Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu, clinical research is centered on immune system processes, with studies focused on preventing serious viral infections and understanding how the body responds to vaccination.

  • Prevention of respiratory syncytial virus infection in infants and young children
  • Evaluation of the safety and effectiveness of a new approach to RSV prevention

This work is designed to improve protection against early-life respiratory illness and to assess how well preventive strategies are tolerated in a pediatric population.

Pediatric Vaccine Studies

The site also supports research in pediatrics and infectious diseases, with a strong focus on human papillomavirus prevention in boys and girls. These studies look at whether simplified vaccination schedules can generate a strong immune response while maintaining safety.

  • Prevention of persistent anogenital HPV infection
  • Protection against disease caused by multiple HPV types

The research aims to support better vaccination strategies for adolescents and to help clarify how the immune system responds over time after vaccination.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Borowska 21350-556 WroclawPoland
Recruiting now
87 trials
Conditions studied
160
Partner status
Verified site

More sites in WroclawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

232 clinical trials

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.

A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Myelofibrosis+3

Recruiting

Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Ryvu Therapeutics S.A.

Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Leo Pharma A/S

Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Medical University Of Lodz

Study on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Keto-Leucine Calcium
  • Sponsor:Agencja Badań Medycznych

Dermatomyositis+1

Recruiting

Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB

Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Agencja Badań Medycznych

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.